Modulating T-cell homeostasis with IL-7

Preclinical and clinical studies

C. M. Capitini, A. A. Chisti, C. L. MacKall

Research output: Contribution to journalArticle

Abstract

Capitini CM, Chisti AA, Mackall CL (National Cancer Institute, National Institutes of Health, Bethesda, MD; USA). Modulating T-cell homeostasis with IL-7: preclinical and clinical studies (Review).J Intern Med 2009; 266: 141-153. Interleukin-7 (IL-7) is required for the development and survival of T cells and plays a critical role in modulating T-cell homeostasis. This review will address current understanding of IL-7 biology, review recent clinical experiences and discuss potential future clinical applications of IL-7, or IL-7 blockade, in the setting of disease.

Original languageEnglish (US)
Pages (from-to)141-153
Number of pages13
JournalJournal of Internal Medicine
Volume266
Issue number2
DOIs
StatePublished - Aug 2009
Externally publishedYes

Fingerprint

Interleukin-7
Homeostasis
T-Lymphocytes
National Cancer Institute (U.S.)
National Institutes of Health (U.S.)
Clinical Studies

Keywords

  • Cytokines
  • Immunotherapy
  • Lymphopenia
  • T cell

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Modulating T-cell homeostasis with IL-7 : Preclinical and clinical studies. / Capitini, C. M.; Chisti, A. A.; MacKall, C. L.

In: Journal of Internal Medicine, Vol. 266, No. 2, 08.2009, p. 141-153.

Research output: Contribution to journalArticle

Capitini, C. M. ; Chisti, A. A. ; MacKall, C. L. / Modulating T-cell homeostasis with IL-7 : Preclinical and clinical studies. In: Journal of Internal Medicine. 2009 ; Vol. 266, No. 2. pp. 141-153.
@article{003644011bd64236b4633e53f79aaac4,
title = "Modulating T-cell homeostasis with IL-7: Preclinical and clinical studies",
abstract = "Capitini CM, Chisti AA, Mackall CL (National Cancer Institute, National Institutes of Health, Bethesda, MD; USA). Modulating T-cell homeostasis with IL-7: preclinical and clinical studies (Review).J Intern Med 2009; 266: 141-153. Interleukin-7 (IL-7) is required for the development and survival of T cells and plays a critical role in modulating T-cell homeostasis. This review will address current understanding of IL-7 biology, review recent clinical experiences and discuss potential future clinical applications of IL-7, or IL-7 blockade, in the setting of disease.",
keywords = "Cytokines, Immunotherapy, Lymphopenia, T cell",
author = "Capitini, {C. M.} and Chisti, {A. A.} and MacKall, {C. L.}",
year = "2009",
month = "8",
doi = "10.1111/j.1365-2796.2009.02085.x",
language = "English (US)",
volume = "266",
pages = "141--153",
journal = "Journal of Internal Medicine",
issn = "0954-6820",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Modulating T-cell homeostasis with IL-7

T2 - Preclinical and clinical studies

AU - Capitini, C. M.

AU - Chisti, A. A.

AU - MacKall, C. L.

PY - 2009/8

Y1 - 2009/8

N2 - Capitini CM, Chisti AA, Mackall CL (National Cancer Institute, National Institutes of Health, Bethesda, MD; USA). Modulating T-cell homeostasis with IL-7: preclinical and clinical studies (Review).J Intern Med 2009; 266: 141-153. Interleukin-7 (IL-7) is required for the development and survival of T cells and plays a critical role in modulating T-cell homeostasis. This review will address current understanding of IL-7 biology, review recent clinical experiences and discuss potential future clinical applications of IL-7, or IL-7 blockade, in the setting of disease.

AB - Capitini CM, Chisti AA, Mackall CL (National Cancer Institute, National Institutes of Health, Bethesda, MD; USA). Modulating T-cell homeostasis with IL-7: preclinical and clinical studies (Review).J Intern Med 2009; 266: 141-153. Interleukin-7 (IL-7) is required for the development and survival of T cells and plays a critical role in modulating T-cell homeostasis. This review will address current understanding of IL-7 biology, review recent clinical experiences and discuss potential future clinical applications of IL-7, or IL-7 blockade, in the setting of disease.

KW - Cytokines

KW - Immunotherapy

KW - Lymphopenia

KW - T cell

UR - http://www.scopus.com/inward/record.url?scp=67650467728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650467728&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2796.2009.02085.x

DO - 10.1111/j.1365-2796.2009.02085.x

M3 - Article

VL - 266

SP - 141

EP - 153

JO - Journal of Internal Medicine

JF - Journal of Internal Medicine

SN - 0954-6820

IS - 2

ER -